Oracle (ORCL) stock dropped 29% YTD despite record $553B AI backlog and strong revenue. Is the debt load justified? Analyst views range from $160-$400. The postOracle (ORCL) stock dropped 29% YTD despite record $553B AI backlog and strong revenue. Is the debt load justified? Analyst views range from $160-$400. The post

Oracle (ORCL) Stock Plunges 29% Despite Record AI Backlog — Is It a Buying Opportunity?

2026/04/13 16:34
Okuma süresi: 4 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.

Key Takeaways

  • Oracle shares have declined approximately 29% year-to-date through early April 2026, even amid robust revenue expansion.
  • Third-quarter fiscal 2026 revenue reached $17.2 billion, representing a 22% year-over-year increase and exceeding analyst forecasts.
  • The company’s remaining performance obligations (RPO) backlog jumped to $553 billion from $455 billion recorded in September 2025.
  • Oracle intends to allocate $50 billion toward capital expenditures in fiscal 2026 and secure another $50 billion via debt and equity financing.
  • Wall Street analysts remain divided, with price projections spanning from $160 to $400, highlighting conflicting views on cash flow generation timing.

Oracle’s market performance this year has emerged as one of Wall Street’s most perplexing narratives. While fundamental metrics appear robust — accelerating revenue and a massive contract pipeline — shares have surrendered nearly one-third of their value since the beginning of January. The disconnect has sparked fierce debate among market watchers.


ORCL Stock Card
Oracle Corporation, ORCL

The enterprise software giant delivered third-quarter fiscal 2026 revenue of $17.2 billion, marking a 21.7% year-over-year climb and surpassing Wall Street’s $16.91 billion projection. Adjusted earnings per share reached $1.79, topping the $1.71 consensus estimate. Management also elevated its fiscal 2027 revenue outlook to $90 billion.

The contract backlog paints an even more compelling picture. Oracle’s remaining performance obligations swelled to $553 billion by March 2026, jumping significantly from the $455 billion figure reported just half a year prior. This represents an extraordinary volume of committed future business.

Yet the market reaction tells a different story.

The Price of Aggressive Expansion

Oracle has disclosed expectations for fiscal 2026 capital spending to hit $50 billion — representing more than a twofold increase versus the previous fiscal year. Management further announced plans to secure an additional $50 billion through combined debt issuance and equity raises to finance cloud infrastructure buildout. The company’s debt burden already approached $100 billion by December 2025.

This represents a substantial financial commitment. Market participants are scrutinizing cash generation metrics closely, recognizing that investment returns from these infrastructure deployments will materialize gradually over an extended timeframe.

Melius analyst Ben Reitzes downgraded the stock to Hold in February, establishing a $160 price target while contending that Oracle merits valuation multiples closer to infrastructure providers rather than traditional software companies — particularly given expectations for limited free cash flow generation until the 2030s, which undermines justification for premium software sector valuations.

Compounding investor concerns, Oracle announced approximately 30,000 workforce reductions through mass electronic communication, a decision that may reduce immediate operating expenses but generated questions surrounding operational execution and employee sentiment.

The Bull-Bear Divide

Not all analysts share this pessimistic outlook. JPMorgan elevated Oracle to Overweight in March, assigning a $210 price target while characterizing the selloff as “drastic” and suggesting the risk-reward profile improved more substantially than actual business fundamentals deteriorated.

Mizuho analyst Siti Panigrahi maintained a Buy recommendation while reducing her price objective from $400 to $320, highlighting Oracle’s cloud infrastructure as challenging for competitors to replicate. She also identified an evolving trend in enterprise artificial intelligence implementation — organizations increasingly prefer deploying AI capabilities where their data currently resides rather than migrating datasets to alternative platforms, a dynamic that advantages Oracle’s positioning.

KeyBanc’s Jackson Ader sustained an Overweight rating with a $300 target, characterizing Oracle as a comprehensive artificial intelligence investment spanning infrastructure layers, application software, and data management. The company’s recently introduced Fusion Agentic Applications — designed for finance, human resources, supply chain management, and customer experience functions — represent a cornerstone of this investment thesis.

Regarding insider transactions, Executive Vice President Douglas Kehring divested 35,000 shares in January at approximately $194.89 per share, decreasing his stake by roughly 51%. CEO Clayton Magouyrk sold 10,000 shares in February at $155.23. Company insiders collectively control 40.9% of outstanding shares.

As of early April trading, ORCL opened at $138.00, significantly below its 52-week peak of $345.72 and nearing its 52-week trough of $121.24. The consensus Wall Street price target stands at $260.71, suggesting considerable upside potential — assuming optimistic analyst projections regarding cash flow timing prove accurate.

The post Oracle (ORCL) Stock Plunges 29% Despite Record AI Backlog — Is It a Buying Opportunity? appeared first on Blockonomi.

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!